Condensed Consolidated Statements of Operations (Unaudited) - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2016 |
Sep. 30, 2015 |
Sep. 30, 2016 |
Sep. 30, 2015 |
|
| Revenues | ||||
| Net Revenues | $ 290,004 | $ 5,890,918 | $ 5,222,529 | $ 28,921,351 |
| Operating expenses: | ||||
| Direct costs of revenue | 336,023 | 1,866,741 | 1,290,326 | 8,566,372 |
| General and administrative expenses | 7,044,462 | 6,082,929 | 18,892,835 | 21,118,902 |
| Sales and marketing expenses | 570,788 | 784,763 | 2,034,499 | 3,106,551 |
| Engineering expenses | 546,525 | 0 | 1,636,702 | 0 |
| Bad debt expense | 3,666,707 | 0 | 3,668,092 | 99,754 |
| Depreciation and amortization | 702,275 | 728,572 | 2,131,232 | 1,979,006 |
| Total operating expenses | 12,866,780 | 9,463,005 | 29,653,686 | 34,870,585 |
| Loss from operations | (12,576,776) | (3,572,087) | (24,431,157) | (5,949,234) |
| Other income (expense): | ||||
| Other income | 127,008 | 0 | 227,020 | 23 |
| Change in fair value of derivative instruments | 2,087,041 | 190,000 | 6,813,701 | 190,000 |
| (Loss) gain on legal settlement | 0 | 0 | (17,652) | 275,028 |
| Interest expense | (1,646,712) | (547,378) | (4,707,453) | (1,594,921) |
| Total other (expense) income | 567,337 | (357,378) | 2,315,616 | (1,129,870) |
| Loss before income taxes | (12,009,439) | (3,929,465) | (22,115,541) | (7,079,104) |
| Income tax benefit | 0 | (2,678,777) | 0 | (2,579,977) |
| Net loss | (12,009,439) | (1,250,688) | (22,115,541) | (4,499,127) |
| Preferred stock dividends | 0 | 268,927 | 0 | 1,589,321 |
| Net loss attributable to common stockholders | $ (12,009,439) | $ (1,519,615) | $ (22,115,541) | $ (6,088,448) |
| Net loss per common share: Basic and diluted | $ (.29) | $ (.05) | $ (.94) | $ (.21) |
| Weighted average number of shares outstanding during the period - Basic and diluted | 41,313,448 | 30,955,483 | 23,574,845 | 29,064,792 |
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. No definition available.
|
| X | ||||||||||
- Definition Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of patient service revenue, net of contractual allowances and discounts, less the related provision for bad debts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
- Definition The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of revenue and income classified as other. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The aggregate value of preferred stock dividends and other adjustments necessary to derive net income apportioned to common stockholders. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of expense related to write-down of receivables to the amount expected to be collected. Includes, but is not limited to, accounts receivable and notes receivable. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). No definition available.
|